TOP-252 HBsAg Decline and Clearance with Peg-Ifn Add-on Therapy – an Individual Participant Data Meta-Analysis of Prospective Trials (PROSPER) | AMiner
TOP-252 HBsAg Decline and Clearance with Peg-Ifn Add-on Therapy – an Individual Participant Data Meta-Analysis of Prospective Trials (PROSPER)